Healthcare provider profile · identity verified

Anthony Lazaro

Family Practice · PLYMOUTH, WI · NPI 1003347451

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	724	186
Amlodipine Besylate	Amlodipine Besylate	636	172
Losartan Potassium	Losartan Potassium	348	100
Gabapentin	Gabapentin	314	57
Levothyroxine Sodium	Levothyroxine Sodium	309	70
Pantoprazole Sodium	Pantoprazole Sodium	288	76
Omeprazole	Omeprazole	278	56
Lisinopril	Lisinopril	269	75
Rosuvastatin Calcium	Rosuvastatin Calcium	259	76
Furosemide	Furosemide	215	57
Duloxetine Hcl	Duloxetine Hcl	210	58
Metoprolol Succinate	Metoprolol Succinate	204	69
Meloxicam	Meloxicam	202	70
Glipizide Er	Glipizide	188	51
Tamsulosin Hcl	Tamsulosin Hcl	188	49
Hydrochlorothiazide	Hydrochlorothiazide	169	47
Metformin Hcl	Metformin Hcl	164	47
Allopurinol	Allopurinol	159	39
Metformin Hcl Er	Metformin Hcl	146	48
Simvastatin	Simvastatin	138	35
Metoprolol Tartrate	Metoprolol Tartrate	129	32
Famotidine	Famotidine	126	26
Pravastatin Sodium	Pravastatin Sodium	122	39
Donepezil Hcl	Donepezil Hcl	116	28
Albuterol Sulfate Hfa	Albuterol Sulfate	106	44
Eliquis	Apixaban	106	25
Sertraline Hcl	Sertraline Hcl	95	23
Tizanidine Hcl	Tizanidine Hcl	89	34
Clopidogrel	Clopidogrel Bisulfate	88	26
Oxybutynin Chloride Er	Oxybutynin Chloride	88	20
Fluticasone Propionate	Fluticasone Propionate	87	31
Ozempic	Semaglutide	79	17
Finasteride	Finasteride	77	25
Spironolactone	Spironolactone	77	23
Escitalopram Oxalate	Escitalopram Oxalate	76	30
Potassium Chloride	Potassium Chloride	76	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	suppressed
Buspirone Hcl	Buspirone Hcl	66	12
Xarelto	Rivaroxaban	66	suppressed
Bupropion Xl	Bupropion Hcl	64	17
Fluoxetine Hcl	Fluoxetine Hcl	61	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	19
Zolpidem Tartrate	Zolpidem Tartrate	58	20
Mirtazapine	Mirtazapine	57	21
Pregabalin	Pregabalin	57	16
Alendronate Sodium	Alendronate Sodium	52	17
Montelukast Sodium	Montelukast Sodium	52	17
Alprazolam	Alprazolam	51	16
Carvedilol	Carvedilol	51	17
Myrbetriq	Mirabegron	51	suppressed
Jardiance	Empagliflozin	50	17
Prednisone	Prednisone	48	35
Chlorthalidone	Chlorthalidone	45	18
Ezetimibe	Ezetimibe	44	13
Trazodone Hcl	Trazodone Hcl	44	16
Doxycycline Hyclate	Doxycycline Hyclate	42	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	12
Synthroid	Levothyroxine Sodium	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	29
Baclofen	Baclofen	35	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Amoxicillin	Amoxicillin	31	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	27
Sucralfate	Sucralfate	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Trulicity	Dulaglutide	29	12
Propranolol Hcl	Propranolol Hcl	28	suppressed
Spiriva Handihaler	Tiotropium Bromide	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Clonazepam	Clonazepam	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	16
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Ondansetron Odt	Ondansetron	22	16
Ramelteon	Ramelteon	22	suppressed
Linzess	Linaclotide	21	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Potassium Citrate Er	Potassium Citrate	19	suppressed
Atenolol	Atenolol	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lorazepam	Lorazepam	18	11
Nifedipine Er	Nifedipine	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	11
Azithromycin	Azithromycin	17	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Nystatin	Nystatin	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	13
Diazepam	Diazepam	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	12	suppressed
Azathioprine	Azathioprine	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Colchicine	Colchicine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error